ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Pharmaceutical Excipient Albumin Market Research Report 2025
Published Date: May 2025
|
Report Code: QYRE-Auto-21Q13483
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Pharmaceutical Excipient Albumin Market Research Report 2023
BUY CHAPTERS

Global Pharmaceutical Excipient Albumin Market Research Report 2025

Code: QYRE-Auto-21Q13483
Report
May 2025
Pages:96
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
CSL Limited
Grifols S A
Takeda
Octapharma AG
Hualan Bio
CBPO
Shanghai Raas
Kedrion S p A
LFB Group
Albumedix
Biotest
Merck
Ventria (InVitria)
Himedia

Pharmaceutical Excipient Albumin Market Size

The global market for Pharmaceutical Excipient Albumin was valued at US$ 842 million in the year 2024 and is projected to reach a revised size of US$ 1432 million by 2031, growing at a CAGR of 8.0% during the forecast period.

Pharmaceutical Excipient Albumin Market

Pharmaceutical Excipient Albumin Market

Albumin is a water-soluble globular protein produced in the liver. It accounts for 50% of blood plasma proteins. These play a vital role in regulating blood volume and act as transporters for molecules such as few hormones, bile salts, and ions. Albumin is commonly used as blood volumizer in rare diseases, burns, shocks, liver conditions, and other blood loss trauma and surgeries
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Pharmaceutical Excipient Albumin, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Pharmaceutical Excipient Albumin.
The Pharmaceutical Excipient Albumin market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Pharmaceutical Excipient Albumin market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Pharmaceutical Excipient Albumin manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Pharmaceutical Excipient Albumin Market Report

Report Metric Details
Report Name Pharmaceutical Excipient Albumin Market
Accounted market size in year US$ 842 million
Forecasted market size in 2031 US$ 1432 million
CAGR 8.0%
Base Year year
Forecasted years 2025 - 2031
Segment by Type
Segment by Application
  • Cell Culture Media
  • Medical Supplements
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company CSL, Grifols, Takeda, Octapharma, Hualan Bio, CBPO, Shanghai RAAS, Kedrion, LFB Group, Albumedix, Biotest, Merck, Ventria (InVitria), HiMedia
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Pharmaceutical Excipient Albumin manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Pharmaceutical Excipient Albumin in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

How fast is Pharmaceutical Excipient Albumin Market growing?

Ans: The Pharmaceutical Excipient Albumin Market witnessing a CAGR of 8.0% during the forecast period 2025-2031.

What is the Pharmaceutical Excipient Albumin Market size in 2031?

Ans: The Pharmaceutical Excipient Albumin Market size in 2031 will be US$ 1432 million.

Who are the main players in the Pharmaceutical Excipient Albumin Market report?

Ans: The main players in the Pharmaceutical Excipient Albumin Market are CSL, Grifols, Takeda, Octapharma, Hualan Bio, CBPO, Shanghai RAAS, Kedrion, LFB Group, Albumedix, Biotest, Merck, Ventria (InVitria), HiMedia

What are the Application segmentation covered in the Pharmaceutical Excipient Albumin Market report?

Ans: The Applications covered in the Pharmaceutical Excipient Albumin Market report are Cell Culture Media, Medical Supplements

What are the Type segmentation covered in the Pharmaceutical Excipient Albumin Market report?

Ans: The Types covered in the Pharmaceutical Excipient Albumin Market report are Human Serum Albumin, Recombinant Albumin

Recommended Reports

Pharma Packaging

Pharma Diagnostics

Pharma Excipients

1 Pharmaceutical Excipient Albumin Market Overview
1.1 Product Definition
1.2 Pharmaceutical Excipient Albumin by Type
1.2.1 Global Pharmaceutical Excipient Albumin Market Value Comparison by Type (2024 VS 2031)
1.2.2 Human Serum Albumin
1.2.3 Recombinant Albumin
1.3 Pharmaceutical Excipient Albumin by Application
1.3.1 Global Pharmaceutical Excipient Albumin Market Value by Application (2024 VS 2031)
1.3.2 Cell Culture Media
1.3.3 Medical Supplements
1.4 Global Pharmaceutical Excipient Albumin Market Size Estimates and Forecasts
1.4.1 Global Pharmaceutical Excipient Albumin Revenue 2020-2031
1.4.2 Global Pharmaceutical Excipient Albumin Sales 2020-2031
1.4.3 Global Pharmaceutical Excipient Albumin Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Pharmaceutical Excipient Albumin Market Competition by Manufacturers
2.1 Global Pharmaceutical Excipient Albumin Sales Market Share by Manufacturers (2020-2025)
2.2 Global Pharmaceutical Excipient Albumin Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Pharmaceutical Excipient Albumin Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Pharmaceutical Excipient Albumin, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Pharmaceutical Excipient Albumin, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Pharmaceutical Excipient Albumin, Product Type & Application
2.7 Global Key Manufacturers of Pharmaceutical Excipient Albumin, Date of Enter into This Industry
2.8 Global Pharmaceutical Excipient Albumin Market Competitive Situation and Trends
2.8.1 Global Pharmaceutical Excipient Albumin Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Pharmaceutical Excipient Albumin Players Market Share by Revenue
2.8.3 Global Pharmaceutical Excipient Albumin Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Pharmaceutical Excipient Albumin Market Scenario by Region
3.1 Global Pharmaceutical Excipient Albumin Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Pharmaceutical Excipient Albumin Sales by Region: 2020-2031
3.2.1 Global Pharmaceutical Excipient Albumin Sales by Region: 2020-2025
3.2.2 Global Pharmaceutical Excipient Albumin Sales by Region: 2026-2031
3.3 Global Pharmaceutical Excipient Albumin Revenue by Region: 2020-2031
3.3.1 Global Pharmaceutical Excipient Albumin Revenue by Region: 2020-2025
3.3.2 Global Pharmaceutical Excipient Albumin Revenue by Region: 2026-2031
3.4 North America Pharmaceutical Excipient Albumin Market Facts & Figures by Country
3.4.1 North America Pharmaceutical Excipient Albumin Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Pharmaceutical Excipient Albumin Sales by Country (2020-2031)
3.4.3 North America Pharmaceutical Excipient Albumin Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe Pharmaceutical Excipient Albumin Market Facts & Figures by Country
3.5.1 Europe Pharmaceutical Excipient Albumin Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Pharmaceutical Excipient Albumin Sales by Country (2020-2031)
3.5.3 Europe Pharmaceutical Excipient Albumin Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Pharmaceutical Excipient Albumin Market Facts & Figures by Region
3.6.1 Asia Pacific Pharmaceutical Excipient Albumin Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Pharmaceutical Excipient Albumin Sales by Region (2020-2031)
3.6.3 Asia Pacific Pharmaceutical Excipient Albumin Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Pharmaceutical Excipient Albumin Market Facts & Figures by Country
3.7.1 Latin America Pharmaceutical Excipient Albumin Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Pharmaceutical Excipient Albumin Sales by Country (2020-2031)
3.7.3 Latin America Pharmaceutical Excipient Albumin Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Pharmaceutical Excipient Albumin Market Facts & Figures by Country
3.8.1 Middle East and Africa Pharmaceutical Excipient Albumin Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Pharmaceutical Excipient Albumin Sales by Country (2020-2031)
3.8.3 Middle East and Africa Pharmaceutical Excipient Albumin Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Pharmaceutical Excipient Albumin Sales by Type (2020-2031)
4.1.1 Global Pharmaceutical Excipient Albumin Sales by Type (2020-2025)
4.1.2 Global Pharmaceutical Excipient Albumin Sales by Type (2026-2031)
4.1.3 Global Pharmaceutical Excipient Albumin Sales Market Share by Type (2020-2031)
4.2 Global Pharmaceutical Excipient Albumin Revenue by Type (2020-2031)
4.2.1 Global Pharmaceutical Excipient Albumin Revenue by Type (2020-2025)
4.2.2 Global Pharmaceutical Excipient Albumin Revenue by Type (2026-2031)
4.2.3 Global Pharmaceutical Excipient Albumin Revenue Market Share by Type (2020-2031)
4.3 Global Pharmaceutical Excipient Albumin Price by Type (2020-2031)
5 Segment by Application
5.1 Global Pharmaceutical Excipient Albumin Sales by Application (2020-2031)
5.1.1 Global Pharmaceutical Excipient Albumin Sales by Application (2020-2025)
5.1.2 Global Pharmaceutical Excipient Albumin Sales by Application (2026-2031)
5.1.3 Global Pharmaceutical Excipient Albumin Sales Market Share by Application (2020-2031)
5.2 Global Pharmaceutical Excipient Albumin Revenue by Application (2020-2031)
5.2.1 Global Pharmaceutical Excipient Albumin Revenue by Application (2020-2025)
5.2.2 Global Pharmaceutical Excipient Albumin Revenue by Application (2026-2031)
5.2.3 Global Pharmaceutical Excipient Albumin Revenue Market Share by Application (2020-2031)
5.3 Global Pharmaceutical Excipient Albumin Price by Application (2020-2031)
6 Key Companies Profiled
6.1 CSL
6.1.1 CSL Company Information
6.1.2 CSL Description and Business Overview
6.1.3 CSL Pharmaceutical Excipient Albumin Sales, Revenue and Gross Margin (2020-2025)
6.1.4 CSL Pharmaceutical Excipient Albumin Product Portfolio
6.1.5 CSL Recent Developments/Updates
6.2 Grifols
6.2.1 Grifols Company Information
6.2.2 Grifols Description and Business Overview
6.2.3 Grifols Pharmaceutical Excipient Albumin Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Grifols Pharmaceutical Excipient Albumin Product Portfolio
6.2.5 Grifols Recent Developments/Updates
6.3 Takeda
6.3.1 Takeda Company Information
6.3.2 Takeda Description and Business Overview
6.3.3 Takeda Pharmaceutical Excipient Albumin Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Takeda Pharmaceutical Excipient Albumin Product Portfolio
6.3.5 Takeda Recent Developments/Updates
6.4 Octapharma
6.4.1 Octapharma Company Information
6.4.2 Octapharma Description and Business Overview
6.4.3 Octapharma Pharmaceutical Excipient Albumin Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Octapharma Pharmaceutical Excipient Albumin Product Portfolio
6.4.5 Octapharma Recent Developments/Updates
6.5 Hualan Bio
6.5.1 Hualan Bio Company Information
6.5.2 Hualan Bio Description and Business Overview
6.5.3 Hualan Bio Pharmaceutical Excipient Albumin Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Hualan Bio Pharmaceutical Excipient Albumin Product Portfolio
6.5.5 Hualan Bio Recent Developments/Updates
6.6 CBPO
6.6.1 CBPO Company Information
6.6.2 CBPO Description and Business Overview
6.6.3 CBPO Pharmaceutical Excipient Albumin Sales, Revenue and Gross Margin (2020-2025)
6.6.4 CBPO Pharmaceutical Excipient Albumin Product Portfolio
6.6.5 CBPO Recent Developments/Updates
6.7 Shanghai RAAS
6.7.1 Shanghai RAAS Company Information
6.7.2 Shanghai RAAS Description and Business Overview
6.7.3 Shanghai RAAS Pharmaceutical Excipient Albumin Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Shanghai RAAS Pharmaceutical Excipient Albumin Product Portfolio
6.7.5 Shanghai RAAS Recent Developments/Updates
6.8 Kedrion
6.8.1 Kedrion Company Information
6.8.2 Kedrion Description and Business Overview
6.8.3 Kedrion Pharmaceutical Excipient Albumin Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Kedrion Pharmaceutical Excipient Albumin Product Portfolio
6.8.5 Kedrion Recent Developments/Updates
6.9 LFB Group
6.9.1 LFB Group Company Information
6.9.2 LFB Group Description and Business Overview
6.9.3 LFB Group Pharmaceutical Excipient Albumin Sales, Revenue and Gross Margin (2020-2025)
6.9.4 LFB Group Pharmaceutical Excipient Albumin Product Portfolio
6.9.5 LFB Group Recent Developments/Updates
6.10 Albumedix
6.10.1 Albumedix Company Information
6.10.2 Albumedix Description and Business Overview
6.10.3 Albumedix Pharmaceutical Excipient Albumin Sales, Revenue and Gross Margin (2020-2025)
6.10.4 Albumedix Pharmaceutical Excipient Albumin Product Portfolio
6.10.5 Albumedix Recent Developments/Updates
6.11 Biotest
6.11.1 Biotest Company Information
6.11.2 Biotest Description and Business Overview
6.11.3 Biotest Pharmaceutical Excipient Albumin Sales, Revenue and Gross Margin (2020-2025)
6.11.4 Biotest Pharmaceutical Excipient Albumin Product Portfolio
6.11.5 Biotest Recent Developments/Updates
6.12 Merck
6.12.1 Merck Company Information
6.12.2 Merck Description and Business Overview
6.12.3 Merck Pharmaceutical Excipient Albumin Sales, Revenue and Gross Margin (2020-2025)
6.12.4 Merck Pharmaceutical Excipient Albumin Product Portfolio
6.12.5 Merck Recent Developments/Updates
6.13 Ventria (InVitria)
6.13.1 Ventria (InVitria) Company Information
6.13.2 Ventria (InVitria) Description and Business Overview
6.13.3 Ventria (InVitria) Pharmaceutical Excipient Albumin Sales, Revenue and Gross Margin (2020-2025)
6.13.4 Ventria (InVitria) Pharmaceutical Excipient Albumin Product Portfolio
6.13.5 Ventria (InVitria) Recent Developments/Updates
6.14 HiMedia
6.14.1 HiMedia Company Information
6.14.2 HiMedia Description and Business Overview
6.14.3 HiMedia Pharmaceutical Excipient Albumin Sales, Revenue and Gross Margin (2020-2025)
6.14.4 HiMedia Pharmaceutical Excipient Albumin Product Portfolio
6.14.5 HiMedia Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Pharmaceutical Excipient Albumin Industry Chain Analysis
7.2 Pharmaceutical Excipient Albumin Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Pharmaceutical Excipient Albumin Production Mode & Process Analysis
7.4 Pharmaceutical Excipient Albumin Sales and Marketing
7.4.1 Pharmaceutical Excipient Albumin Sales Channels
7.4.2 Pharmaceutical Excipient Albumin Distributors
7.5 Pharmaceutical Excipient Albumin Customer Analysis
8 Pharmaceutical Excipient Albumin Market Dynamics
8.1 Pharmaceutical Excipient Albumin Industry Trends
8.2 Pharmaceutical Excipient Albumin Market Drivers
8.3 Pharmaceutical Excipient Albumin Market Challenges
8.4 Pharmaceutical Excipient Albumin Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
CSL Limited
Grifols S A
Takeda
Octapharma AG
Hualan Bio
CBPO
Shanghai Raas
Kedrion S p A
LFB Group
Albumedix
Biotest
Merck
Ventria (InVitria)
Himedia
List of Tables
 Table 1. Global Pharmaceutical Excipient Albumin Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Pharmaceutical Excipient Albumin Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Pharmaceutical Excipient Albumin Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Pharmaceutical Excipient Albumin Sales (K Units) of Key Manufacturers (2020-2025)
 Table 5. Global Pharmaceutical Excipient Albumin Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Pharmaceutical Excipient Albumin Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Pharmaceutical Excipient Albumin Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Pharmaceutical Excipient Albumin Average Price (US$/Unit) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Pharmaceutical Excipient Albumin, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Pharmaceutical Excipient Albumin, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Pharmaceutical Excipient Albumin, Product Type & Application
 Table 12. Global Key Manufacturers of Pharmaceutical Excipient Albumin, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Pharmaceutical Excipient Albumin by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pharmaceutical Excipient Albumin as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Pharmaceutical Excipient Albumin Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Pharmaceutical Excipient Albumin Sales by Region (2020-2025) & (K Units)
 Table 18. Global Pharmaceutical Excipient Albumin Sales Market Share by Region (2020-2025)
 Table 19. Global Pharmaceutical Excipient Albumin Sales by Region (2026-2031) & (K Units)
 Table 20. Global Pharmaceutical Excipient Albumin Sales Market Share by Region (2026-2031)
 Table 21. Global Pharmaceutical Excipient Albumin Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Pharmaceutical Excipient Albumin Revenue Market Share by Region (2020-2025)
 Table 23. Global Pharmaceutical Excipient Albumin Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Pharmaceutical Excipient Albumin Revenue Market Share by Region (2026-2031)
 Table 25. North America Pharmaceutical Excipient Albumin Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Pharmaceutical Excipient Albumin Sales by Country (2020-2025) & (K Units)
 Table 27. North America Pharmaceutical Excipient Albumin Sales by Country (2026-2031) & (K Units)
 Table 28. North America Pharmaceutical Excipient Albumin Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Pharmaceutical Excipient Albumin Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Pharmaceutical Excipient Albumin Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Pharmaceutical Excipient Albumin Sales by Country (2020-2025) & (K Units)
 Table 32. Europe Pharmaceutical Excipient Albumin Sales by Country (2026-2031) & (K Units)
 Table 33. Europe Pharmaceutical Excipient Albumin Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Pharmaceutical Excipient Albumin Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Pharmaceutical Excipient Albumin Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Pharmaceutical Excipient Albumin Sales by Region (2020-2025) & (K Units)
 Table 37. Asia Pacific Pharmaceutical Excipient Albumin Sales by Region (2026-2031) & (K Units)
 Table 38. Asia Pacific Pharmaceutical Excipient Albumin Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Pharmaceutical Excipient Albumin Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Pharmaceutical Excipient Albumin Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Pharmaceutical Excipient Albumin Sales by Country (2020-2025) & (K Units)
 Table 42. Latin America Pharmaceutical Excipient Albumin Sales by Country (2026-2031) & (K Units)
 Table 43. Latin America Pharmaceutical Excipient Albumin Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Pharmaceutical Excipient Albumin Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Pharmaceutical Excipient Albumin Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Pharmaceutical Excipient Albumin Sales by Country (2020-2025) & (K Units)
 Table 47. Middle East and Africa Pharmaceutical Excipient Albumin Sales by Country (2026-2031) & (K Units)
 Table 48. Middle East and Africa Pharmaceutical Excipient Albumin Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Pharmaceutical Excipient Albumin Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Pharmaceutical Excipient Albumin Sales (K Units) by Type (2020-2025)
 Table 51. Global Pharmaceutical Excipient Albumin Sales (K Units) by Type (2026-2031)
 Table 52. Global Pharmaceutical Excipient Albumin Sales Market Share by Type (2020-2025)
 Table 53. Global Pharmaceutical Excipient Albumin Sales Market Share by Type (2026-2031)
 Table 54. Global Pharmaceutical Excipient Albumin Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Pharmaceutical Excipient Albumin Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Pharmaceutical Excipient Albumin Revenue Market Share by Type (2020-2025)
 Table 57. Global Pharmaceutical Excipient Albumin Revenue Market Share by Type (2026-2031)
 Table 58. Global Pharmaceutical Excipient Albumin Price (US$/Unit) by Type (2020-2025)
 Table 59. Global Pharmaceutical Excipient Albumin Price (US$/Unit) by Type (2026-2031)
 Table 60. Global Pharmaceutical Excipient Albumin Sales (K Units) by Application (2020-2025)
 Table 61. Global Pharmaceutical Excipient Albumin Sales (K Units) by Application (2026-2031)
 Table 62. Global Pharmaceutical Excipient Albumin Sales Market Share by Application (2020-2025)
 Table 63. Global Pharmaceutical Excipient Albumin Sales Market Share by Application (2026-2031)
 Table 64. Global Pharmaceutical Excipient Albumin Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Pharmaceutical Excipient Albumin Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Pharmaceutical Excipient Albumin Revenue Market Share by Application (2020-2025)
 Table 67. Global Pharmaceutical Excipient Albumin Revenue Market Share by Application (2026-2031)
 Table 68. Global Pharmaceutical Excipient Albumin Price (US$/Unit) by Application (2020-2025)
 Table 69. Global Pharmaceutical Excipient Albumin Price (US$/Unit) by Application (2026-2031)
 Table 70. CSL Company Information
 Table 71. CSL Description and Business Overview
 Table 72. CSL Pharmaceutical Excipient Albumin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 73. CSL Pharmaceutical Excipient Albumin Product
 Table 74. CSL Recent Developments/Updates
 Table 75. Grifols Company Information
 Table 76. Grifols Description and Business Overview
 Table 77. Grifols Pharmaceutical Excipient Albumin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 78. Grifols Pharmaceutical Excipient Albumin Product
 Table 79. Grifols Recent Developments/Updates
 Table 80. Takeda Company Information
 Table 81. Takeda Description and Business Overview
 Table 82. Takeda Pharmaceutical Excipient Albumin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 83. Takeda Pharmaceutical Excipient Albumin Product
 Table 84. Takeda Recent Developments/Updates
 Table 85. Octapharma Company Information
 Table 86. Octapharma Description and Business Overview
 Table 87. Octapharma Pharmaceutical Excipient Albumin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 88. Octapharma Pharmaceutical Excipient Albumin Product
 Table 89. Octapharma Recent Developments/Updates
 Table 90. Hualan Bio Company Information
 Table 91. Hualan Bio Description and Business Overview
 Table 92. Hualan Bio Pharmaceutical Excipient Albumin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 93. Hualan Bio Pharmaceutical Excipient Albumin Product
 Table 94. Hualan Bio Recent Developments/Updates
 Table 95. CBPO Company Information
 Table 96. CBPO Description and Business Overview
 Table 97. CBPO Pharmaceutical Excipient Albumin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 98. CBPO Pharmaceutical Excipient Albumin Product
 Table 99. CBPO Recent Developments/Updates
 Table 100. Shanghai RAAS Company Information
 Table 101. Shanghai RAAS Description and Business Overview
 Table 102. Shanghai RAAS Pharmaceutical Excipient Albumin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 103. Shanghai RAAS Pharmaceutical Excipient Albumin Product
 Table 104. Shanghai RAAS Recent Developments/Updates
 Table 105. Kedrion Company Information
 Table 106. Kedrion Description and Business Overview
 Table 107. Kedrion Pharmaceutical Excipient Albumin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 108. Kedrion Pharmaceutical Excipient Albumin Product
 Table 109. Kedrion Recent Developments/Updates
 Table 110. LFB Group Company Information
 Table 111. LFB Group Description and Business Overview
 Table 112. LFB Group Pharmaceutical Excipient Albumin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 113. LFB Group Pharmaceutical Excipient Albumin Product
 Table 114. LFB Group Recent Developments/Updates
 Table 115. Albumedix Company Information
 Table 116. Albumedix Description and Business Overview
 Table 117. Albumedix Pharmaceutical Excipient Albumin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 118. Albumedix Pharmaceutical Excipient Albumin Product
 Table 119. Albumedix Recent Developments/Updates
 Table 120. Biotest Company Information
 Table 121. Biotest Description and Business Overview
 Table 122. Biotest Pharmaceutical Excipient Albumin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 123. Biotest Pharmaceutical Excipient Albumin Product
 Table 124. Biotest Recent Developments/Updates
 Table 125. Merck Company Information
 Table 126. Merck Description and Business Overview
 Table 127. Merck Pharmaceutical Excipient Albumin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 128. Merck Pharmaceutical Excipient Albumin Product
 Table 129. Merck Recent Developments/Updates
 Table 130. Ventria (InVitria) Company Information
 Table 131. Ventria (InVitria) Description and Business Overview
 Table 132. Ventria (InVitria) Pharmaceutical Excipient Albumin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 133. Ventria (InVitria) Pharmaceutical Excipient Albumin Product
 Table 134. Ventria (InVitria) Recent Developments/Updates
 Table 135. HiMedia Company Information
 Table 136. HiMedia Description and Business Overview
 Table 137. HiMedia Pharmaceutical Excipient Albumin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 138. HiMedia Pharmaceutical Excipient Albumin Product
 Table 139. HiMedia Recent Developments/Updates
 Table 140. Key Raw Materials Lists
 Table 141. Raw Materials Key Suppliers Lists
 Table 142. Pharmaceutical Excipient Albumin Distributors List
 Table 143. Pharmaceutical Excipient Albumin Customers List
 Table 144. Pharmaceutical Excipient Albumin Market Trends
 Table 145. Pharmaceutical Excipient Albumin Market Drivers
 Table 146. Pharmaceutical Excipient Albumin Market Challenges
 Table 147. Pharmaceutical Excipient Albumin Market Restraints
 Table 148. Research Programs/Design for This Report
 Table 149. Key Data Information from Secondary Sources
 Table 150. Key Data Information from Primary Sources
 Table 151. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Pharmaceutical Excipient Albumin
 Figure 2. Global Pharmaceutical Excipient Albumin Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Pharmaceutical Excipient Albumin Market Share by Type: 2024 & 2031
 Figure 4. Human Serum Albumin Product Picture
 Figure 5. Recombinant Albumin Product Picture
 Figure 6. Global Pharmaceutical Excipient Albumin Market Value by Application (2020-2031) & (US$ Million)
 Figure 7. Global Pharmaceutical Excipient Albumin Market Share by Application: 2024 & 2031
 Figure 8. Cell Culture Media
 Figure 9. Medical Supplements
 Figure 10. Global Pharmaceutical Excipient Albumin Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 11. Global Pharmaceutical Excipient Albumin Market Size (2020-2031) & (US$ Million)
 Figure 12. Global Pharmaceutical Excipient Albumin Sales (2020-2031) & (K Units)
 Figure 13. Global Pharmaceutical Excipient Albumin Average Price (US$/Unit) & (2020-2031)
 Figure 14. Pharmaceutical Excipient Albumin Report Years Considered
 Figure 15. Pharmaceutical Excipient Albumin Sales Share by Manufacturers in 2024
 Figure 16. Global Pharmaceutical Excipient Albumin Revenue Share by Manufacturers in 2024
 Figure 17. Global 5 and 10 Largest Pharmaceutical Excipient Albumin Players: Market Share by Revenue in Pharmaceutical Excipient Albumin in 2024
 Figure 18. Pharmaceutical Excipient Albumin Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 19. Global Pharmaceutical Excipient Albumin Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 20. North America Pharmaceutical Excipient Albumin Sales Market Share by Country (2020-2031)
 Figure 21. North America Pharmaceutical Excipient Albumin Revenue Market Share by Country (2020-2031)
 Figure 22. United States Pharmaceutical Excipient Albumin Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 23. Canada Pharmaceutical Excipient Albumin Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 24. Europe Pharmaceutical Excipient Albumin Sales Market Share by Country (2020-2031)
 Figure 25. Europe Pharmaceutical Excipient Albumin Revenue Market Share by Country (2020-2031)
 Figure 26. Germany Pharmaceutical Excipient Albumin Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 27. France Pharmaceutical Excipient Albumin Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 28. U.K. Pharmaceutical Excipient Albumin Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 29. Italy Pharmaceutical Excipient Albumin Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 30. Russia Pharmaceutical Excipient Albumin Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. Asia Pacific Pharmaceutical Excipient Albumin Sales Market Share by Region (2020-2031)
 Figure 32. Asia Pacific Pharmaceutical Excipient Albumin Revenue Market Share by Region (2020-2031)
 Figure 33. China Pharmaceutical Excipient Albumin Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 34. Japan Pharmaceutical Excipient Albumin Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 35. South Korea Pharmaceutical Excipient Albumin Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 36. India Pharmaceutical Excipient Albumin Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 37. Australia Pharmaceutical Excipient Albumin Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. China Taiwan Pharmaceutical Excipient Albumin Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. Southeast Asia Pharmaceutical Excipient Albumin Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. Latin America Pharmaceutical Excipient Albumin Sales Market Share by Country (2020-2031)
 Figure 41. Latin America Pharmaceutical Excipient Albumin Revenue Market Share by Country (2020-2031)
 Figure 42. Mexico Pharmaceutical Excipient Albumin Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 43. Brazil Pharmaceutical Excipient Albumin Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 44. Argentina Pharmaceutical Excipient Albumin Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 45. Middle East and Africa Pharmaceutical Excipient Albumin Sales Market Share by Country (2020-2031)
 Figure 46. Middle East and Africa Pharmaceutical Excipient Albumin Revenue Market Share by Country (2020-2031)
 Figure 47. Turkey Pharmaceutical Excipient Albumin Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 48. Saudi Arabia Pharmaceutical Excipient Albumin Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 49. UAE Pharmaceutical Excipient Albumin Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 50. Global Sales Market Share of Pharmaceutical Excipient Albumin by Type (2020-2031)
 Figure 51. Global Revenue Market Share of Pharmaceutical Excipient Albumin by Type (2020-2031)
 Figure 52. Global Pharmaceutical Excipient Albumin Price (US$/Unit) by Type (2020-2031)
 Figure 53. Global Sales Market Share of Pharmaceutical Excipient Albumin by Application (2020-2031)
 Figure 54. Global Revenue Market Share of Pharmaceutical Excipient Albumin by Application (2020-2031)
 Figure 55. Global Pharmaceutical Excipient Albumin Price (US$/Unit) by Application (2020-2031)
 Figure 56. Pharmaceutical Excipient Albumin Value Chain
 Figure 57. Channels of Distribution (Direct Vs Distribution)
 Figure 58. Bottom-up and Top-down Approaches for This Report
 Figure 59. Data Triangulation
 Figure 60. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Accenture

SIMILAR REPORTS

Albumin Excipient Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Albumin as Excipient Market Insights Forecast to 2030
Plasma Albumin Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Human Serum Albumin Market Research Report 2025
Blood Albumin Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Albumin Market Research Report 2025
Global Albumin Pharmaceutical Preparations Market Research Report 2024
Human Albumin Injection Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Human Albumin Solution Market Research Report 2024
Human Serum Albumin Fusion Protein Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Albumin Testing Market Research Report 2024
Global rHu Albumin Market Research Report 2024
Blood Plasma Products Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Blood Banking and Blood Products Market Research Report 2024
Dry Bovine Serum Albumin Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Colloids Blood Plasma Market Research Report 2025
Global Plasma Protein Products Market Research Report 2024
Global Albumin Human Market Research Report 2024
Protein Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Recombinant Albumin Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

RELATED REPORTS

Global Pharma and Healthcare Social Media Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-14Y6812
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Food Additives Testing Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-34O3983
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Gabapentin API Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-9V17601
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Electronic Informed Consent Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-22C17047
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions